• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

突变预防浓度的变化。

Variation in Mutant Prevention Concentrations.

作者信息

Gianvecchio Crystal, Lozano Natalie Ann, Henderson Claire, Kalhori Pooneh, Bullivant Austin, Valencia Alondra, Su Lauren, Bello Gladys, Wong Michele, Cook Emoni, Fuller Lakhia, Neal Jerome B, Yeh Pamela J

机构信息

Department of Ecology and Evolutionary Biology, University of California, Los Angeles, Los Angeles, CA, United States.

Santa Fe Institute, Santa Fe, NM, United States.

出版信息

Front Microbiol. 2019 Jan 31;10:42. doi: 10.3389/fmicb.2019.00042. eCollection 2019.

DOI:10.3389/fmicb.2019.00042
PMID:30766517
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6365975/
Abstract

Understanding how phenotypic traits vary has been a longstanding goal of evolutionary biologists. When examining antibiotic-resistance in bacteria, it is generally understood that the minimum inhibitory concentration (MIC) has minimal variation specific to each bacterial strain-antibiotic combination. However, there is a less studied resistance trait, the mutant prevention concentration (MPC), which measures the MIC of the most resistant sub-population. Whether and how MPC varies has been poorly understood. Here, we ask a simple, yet important question: How much does the MPC vary, within a single strain-antibiotic association? Using a species and five antibiotics from five different antibiotic classes-ciprofloxacin, doxycycline, gentamicin, nitrofurantoin, and oxacillin-we examined the frequency of resistance for a wide range of concentrations per antibiotic, and measured the repeatability of the MPC, the lowest amount of antibiotic that would ensure no surviving cells in a 10 population of bacteria. We found a wide variation within the MPC and distributions that were rarely normal. When antibiotic resistance evolved, the distribution of the MPC changed, with all distributions becoming wider and some multi-modal. Unlike the MIC, there is high variability in the MPC for a given bacterial strain-antibiotic combination.

摘要

理解表型性状如何变化一直是进化生物学家长期以来的目标。在研究细菌的抗生素耐药性时,通常认为最低抑菌浓度(MIC)对于每种细菌菌株 - 抗生素组合具有最小的变异性。然而,有一种研究较少的耐药性状,即突变预防浓度(MPC),它衡量的是最耐药亚群的MIC。MPC是否以及如何变化一直鲜为人知。在这里,我们提出一个简单却重要的问题:在单一菌株 - 抗生素组合中,MPC的变化有多大?我们使用一种细菌物种以及来自五种不同抗生素类别的五种抗生素——环丙沙星、强力霉素、庆大霉素、呋喃妥因和苯唑西林——检测了每种抗生素在广泛浓度范围内的耐药频率,并测量了MPC的重复性,MPC是能确保在10个细菌群体中无存活细胞所需的最低抗生素量。我们发现MPC存在广泛的变异性,且分布很少呈正态分布。当抗生素耐药性进化时,MPC的分布发生了变化,所有分布都变宽了,有些还呈现多峰分布。与MIC不同,对于给定的细菌菌株 - 抗生素组合,MPC具有很高的变异性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edbb/6365975/ec8ef1e3769e/fmicb-10-00042-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edbb/6365975/3dddd1506468/fmicb-10-00042-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edbb/6365975/7b479b1c406c/fmicb-10-00042-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edbb/6365975/ec8ef1e3769e/fmicb-10-00042-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edbb/6365975/3dddd1506468/fmicb-10-00042-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edbb/6365975/7b479b1c406c/fmicb-10-00042-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edbb/6365975/ec8ef1e3769e/fmicb-10-00042-g003.jpg

相似文献

1
Variation in Mutant Prevention Concentrations.突变预防浓度的变化。
Front Microbiol. 2019 Jan 31;10:42. doi: 10.3389/fmicb.2019.00042. eCollection 2019.
2
Evolution of antibiotic cross-resistance and collateral sensitivity in using the mutant prevention concentration and the mutant selection window.利用突变预防浓度和突变选择窗研究抗生素交叉耐药性及协同敏感性的演变
Evol Appl. 2020 Feb 25;13(4):808-823. doi: 10.1111/eva.12903. eCollection 2020 Apr.
3
Predictors of bacterial resistance using in vitro dynamic models: area under the concentration-time curve related to either the minimum inhibitory or mutant prevention antibiotic concentration.利用体外动态模型预测细菌耐药性:与最小抑菌浓度或突变预防抗生素浓度相关的浓度时间曲线下面积。
J Antimicrob Chemother. 2016 Mar;71(3):678-84. doi: 10.1093/jac/dkv387. Epub 2015 Nov 30.
4
Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model.在体外动态模型中,用暴露于达托霉素和万古霉素的金黄色葡萄球菌检验突变选择窗假说。
J Antimicrob Chemother. 2006 Dec;58(6):1185-92. doi: 10.1093/jac/dkl387. Epub 2006 Oct 5.
5
Predicting antibiotic combination effects on the selection of resistant Staphylococcus aureus: In vitro model studies with linezolid and gentamicin.预测抗生素联合作用对耐甲氧西林金黄色葡萄球菌选择的影响:利奈唑胺和庆大霉素的体外模型研究。
Int J Antimicrob Agents. 2018 Dec;52(6):854-860. doi: 10.1016/j.ijantimicag.2018.09.005. Epub 2018 Sep 17.
6
[The concentrations of fluoroquinolones in prevention of Staphylococcus epidermidis from mutant in ocular surface].[氟喹诺酮类药物在预防眼表表皮葡萄球菌突变中的浓度]
Zhonghua Yan Ke Za Zhi. 2006 Nov;42(11):989-91.
7
Enrichment of resistant Staphylococcus aureus at ciprofloxacin concentrations simulated within the mutant selection window: bolus versus continuous infusion.在突变选择窗内模拟的环丙沙星浓度下耐甲氧西林金黄色葡萄球菌的富集:推注与持续输注
Int J Antimicrob Agents. 2008 Dec;32(6):488-93. doi: 10.1016/j.ijantimicag.2008.06.031. Epub 2008 Sep 14.
8
Selection of ciprofloxacin resistance in Escherichia coli in an in vitro kinetic model: relation between drug exposure and mutant prevention concentration.体外动力学模型中大肠杆菌对环丙沙星耐药性的选择:药物暴露与突变预防浓度之间的关系
J Antimicrob Chemother. 2006 Jun;57(6):1116-21. doi: 10.1093/jac/dkl135. Epub 2006 Apr 19.
9
In vitro resistance studies with bacteria that exhibit low mutation frequencies: prediction of "antimutant" linezolid concentrations using a mixed inoculum containing both susceptible and resistant Staphylococcus aureus.对突变频率较低的细菌进行的体外耐药性研究:使用含有敏感和耐药金黄色葡萄球菌的混合接种物预测“抗突变”利奈唑胺浓度。
Antimicrob Agents Chemother. 2015 Feb;59(2):1014-9. doi: 10.1128/AAC.04214-14. Epub 2014 Dec 1.
10
Comparative mutant prevention concentration and mechanism of resistance to veterinary fluoroquinolones in Staphylococcus pseudintermedius.中间型葡萄球菌对兽用氟喹诺酮类药物的比较突变预防浓度及耐药机制
Vet Dermatol. 2012 Aug;23(4):376-80, e68-9. doi: 10.1111/j.1365-3164.2012.01038.x. Epub 2012 Mar 12.

引用本文的文献

1
Is Rifampin (Rifampicin) Essential for the Treatment of Rhodococcus equi Infections in Foals? A Critical Review of the Role of Rifampin.利福平对治疗幼驹马红球菌感染是否必不可少?对利福平作用的批判性综述。
J Vet Pharmacol Ther. 2025 Sep;48(5):345-358. doi: 10.1111/jvp.70007. Epub 2025 Jun 24.
2
Simulation of a field condition to evaluate the risk of enrofloxacin-resistant strain selection in food producing rabbits treated via drinking water.模拟田间条件以评估通过饮用水给药的食用兔中耐恩诺沙星菌株选择的风险。
Front Vet Sci. 2025 Feb 13;12:1474409. doi: 10.3389/fvets.2025.1474409. eCollection 2025.
3
Pharmacokinetics and Pharmacodynamics Evaluation of Amoxicillin Against in Dogs.

本文引用的文献

1
Emergence of Global Antibiotic Resistance.全球抗生素耐药性的出现
Prim Care. 2018 Sep;45(3):467-484. doi: 10.1016/j.pop.2018.05.006.
2
MIC-based dose adjustment: facts and fables.基于 MIC 的剂量调整:事实与虚构。
J Antimicrob Chemother. 2018 Mar 1;73(3):564-568. doi: 10.1093/jac/dkx427.
3
Revisiting the mutant prevention concentration to guide dosing in childhood tuberculosis.重新审视突变预防浓度以指导儿童结核病的给药
阿莫西林对犬的药代动力学和药效学评价
Pathogens. 2024 Dec 19;13(12):1121. doi: 10.3390/pathogens13121121.
4
Artificial Intelligence to Close the Gap between Pharmacokinetic/Pharmacodynamic Targets and Clinical Outcomes in Critically Ill Patients: A Narrative Review on Beta Lactams.人工智能缩小重症患者药代动力学/药效学靶点与临床结局之间的差距:关于β-内酰胺类药物的叙述性综述
Antibiotics (Basel). 2024 Sep 6;13(9):853. doi: 10.3390/antibiotics13090853.
5
In Vitro Resistance-Predicting Studies and In Vitro Resistance-Related Parameters-A Hit-to-Lead Perspective.体外抗性预测研究及体外抗性相关参数——从苗头化合物到先导化合物的视角
Pharmaceuticals (Basel). 2024 Aug 15;17(8):1068. doi: 10.3390/ph17081068.
6
In Vitro Antibacterial Activities of Fosfomycin against Isolates from Canine Urinary Tract Infection.磷霉素对犬尿路感染分离株的体外抗菌活性
Animals (Basel). 2024 Jun 28;14(13):1916. doi: 10.3390/ani14131916.
7
Repurposing harmaline as a novel approach to reverse tmexCD1-toprJ1-mediated tigecycline resistance against klebsiella pneumoniae infections.将 harmaline 重新用作一种新方法来逆转 tmexCD1-toprJ1 介导的肺炎克雷伯氏菌感染对替加环素的耐药性。
Microb Cell Fact. 2024 May 24;23(1):152. doi: 10.1186/s12934-024-02410-4.
8
Alternate Antimicrobial Therapies and Their Companion Tests.替代抗菌疗法及其配套检测
Diagnostics (Basel). 2023 Jul 26;13(15):2490. doi: 10.3390/diagnostics13152490.
9
Mutant Prevention Concentration, Frequency of Spontaneous Mutant Selection, and Mutant Selection Window-a New Approach to the Determination of the Antimicrobial Potency of Compounds.突变预防浓度、自发突变选择频率和突变选择窗——一种新的确定化合物抗菌效力的方法。
Antimicrob Agents Chemother. 2023 May 17;67(5):e0137322. doi: 10.1128/aac.01373-22. Epub 2023 Apr 6.
10
Developmental Pharmacokinetics of Antibiotics Used in Neonatal ICU: Focus on Preterm Infants.新生儿重症监护病房使用的抗生素的发育药代动力学:关注早产儿。
Biomedicines. 2023 Mar 17;11(3):940. doi: 10.3390/biomedicines11030940.
J Antimicrob Chemother. 2017 Jul 1;72(7):1848-1857. doi: 10.1093/jac/dkx051.
4
Determination of the Mutant Selection Window and Evaluation of the Killing of Mycoplasma gallisepticum by Danofloxacin, Doxycycline, Tilmicosin, Tylvalosin and Valnemulin.达氟沙星、多西环素、替米考星、泰万菌素和沃尼妙林对鸡毒支原体的突变选择窗测定及杀菌效果评估
PLoS One. 2017 Jan 4;12(1):e0169134. doi: 10.1371/journal.pone.0169134. eCollection 2017.
5
Efficacy of High-Dose Meropenem (Six Grams per Day) in Treatment of Experimental Murine Pneumonia Induced by Meropenem-Resistant Pseudomonas aeruginosa.高剂量美罗培南(每日6克)治疗耐美罗培南铜绿假单胞菌所致实验性小鼠肺炎的疗效
Antimicrob Agents Chemother. 2016 Dec 27;61(1). doi: 10.1128/AAC.02056-16. Print 2017 Jan.
6
Antibiotic Restriction Might Facilitate the Emergence of Multi-drug Resistance.抗生素限制可能会促进多重耐药性的出现。
PLoS Comput Biol. 2015 Jun 25;11(6):e1004340. doi: 10.1371/journal.pcbi.1004340. eCollection 2015 Jun.
7
Comparative study of the mutant prevention concentrations of vancomycin alone and in combination with levofloxacin, rifampicin and fosfomycin against methicillin-resistant Staphylococcus epidermidis.万古霉素单独及联合左氧氟沙星、利福平、磷霉素对耐甲氧西林表皮葡萄球菌突变预防浓度的比较研究。
J Antibiot (Tokyo). 2013 Dec;66(12):709-12. doi: 10.1038/ja.2013.87. Epub 2013 Aug 28.
8
Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis.不同谱系结核分枝杆菌突变率的估计预测了耐药性结核分枝杆菌的出现有很大差异。
Nat Genet. 2013 Jul;45(7):784-90. doi: 10.1038/ng.2656. Epub 2013 Jun 9.
9
Evolutionary paths to antibiotic resistance under dynamically sustained drug selection.动态维持药物选择下抗生素耐药性的进化途径。
Nat Genet. 2011 Dec 18;44(1):101-5. doi: 10.1038/ng.1034.
10
The rising problem of antimicrobial resistance in the intensive care unit.重症监护病房中抗菌药物耐药性日益严重的问题。
Ann Intensive Care. 2011 Nov 23;1:47. doi: 10.1186/2110-5820-1-47.